Eton Pharmaceuticals (ETON) Interest Coverage Ratio (2018 - 2025)
Eton Pharmaceuticals (ETON) reported Interest Coverage Ratio of 2.65 for Q4 2025, down 41.03% on a YoY basis from 4.49 in Q4 2024, and up 19104.01% sequentially from 0.01 in Q3 2025.
Eton Pharmaceuticals (ETON) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 8 years of Interest Coverage Ratio data on file, last reported at 2.65 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 41.03% year-over-year to 2.65; the trailing twelve-month figure through Dec 2025 stood at 0.44 (up 75.89% YoY), and the FY2025 full-year result was 0.01, up 75.59% from the prior year.
- Interest Coverage Ratio rose to 2.65 in Q4 2025, from 0.01 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 20.31 in Q1 2021 to a low of 8.57 in Q3 2021.
- A 5-year average of 0.43 and a median of 0.11 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio plunged 1470.86% in 2021 and surged 705.79% in 2023, its largest moves.
- Tracing ETON's Interest Coverage Ratio over 5 years: stood at 2.99 in 2021, then slipped by 13.46% to 2.59 in 2022, then slumped by 282.33% to 4.72 in 2023, then jumped by 195.13% to 4.49 in 2024, then slumped by 41.03% to 2.65 in 2025.
- Business Quant data shows ETON's Interest Coverage Ratio at 2.65 in Q4 2025, 0.01 in Q3 2025, and 0.03 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 2.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.65 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | 4.49 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | -4.63 |
| Mar 31, 2024 | -1.31 |
| Dec 31, 2023 | -4.72 |
| Sep 30, 2023 | -0.20 |
| Jun 30, 2023 | 5.17 |
| Mar 31, 2023 | -4.17 |
| Dec 31, 2022 | 2.59 |
| Sep 30, 2022 | -1.56 |
| Jun 30, 2022 | -0.85 |
| Mar 31, 2022 | -3.19 |
| Dec 31, 2021 | 2.99 |
| Sep 30, 2021 | -8.57 |
| Jun 30, 2021 | -0.37 |
| Mar 31, 2021 | 20.31 |